Brochures, Pharmaceutical

Analytical Services in the Development of MDIs and DPIs

Pressurized metered dose inhalers and dry powder inhalers are challenging to develop whether as new drug products or generics. This brochure details the analytical services that Gateway Analytical, a company that specializes in particle characterization and particulate analysis, offers for these vital products in the management and treatment of asthma and COPD. The Gateway Analytical team has regulatory and scientific expertise, extensive experience in pharmaceutical testing and a wide range of instrumentation at its disposal. A defining focus for pressurized metered dose inhaler and dry powder inhaler testing is chemically-specific particle characterization via techniques such as automated Raman Chemical Imaging, Raman Spectroscopy, Laser-induced breakdown spectroscopy, and Scanning Electron Microscopy/Energy Dispersive Spectroscopy.

Via single particle characterization and/or analyses for complete particle populations Gateway Analytical enables scientists to elucidate deagglomeration/dispersion behavior, examine the performance of drug products with multiple actives, and identify foreign contaminants. The analytical services provided support activities from discovery and development, through clinical trials and in-vitro bioequivalence testing to commercial manufacturing and safety monitoring. In this way Gateway Analytical can help you to accelerate the commercialization of your pressurized metered dose inhalers and dry powder inhalers to   ensure these reach commercialization as quickly as possible.

Download Brochure "Analytical Services in the Development of MDIs and DPIs"
25 Nov 2022

Learn more about Aptar Pharma Services

Find Out More About Aptar Pharma Services

Learn more about Aptar Pharma Expertise
in Pulmonary Drug Delivery

Find Out More About pulmonary drug delivery expertise

This Might Also Be of Interest

22 Apr 2024

Navigating the Shift to more sustainable Low GWP propellants in pMDIs

Publications, Pharmaceutical, Sustainability, Brand Differentiation, Market Insights, Product Solutions

Read More
18 Dec 2023

Elevating Medication Adherence and Clinical Outcomes with Connected Drug Delivery

Publications, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
13 Dec 2023

Advancing Inhaled & Nasal Drug Clinical Studies: Insights & Strategies

Webinars, Pharmaceutical, Market Insights, Product Solutions, Device Innovations

Read More
10 May 2023

Navigating the Development for Orally Inhaled and Nasal Drug Products

Publications, Pharmaceutical, Market Insights, Product Solutions, Device Innovations

Read More
1 2 3 15

Request Access

Close

Requesting access to Analytical Services in the Development of MDIs and DPIs.

  • This field is for validation purposes and should be left unchanged.
Back To Top